Comparison

(+)-CBI-CDPI2 European Partner

Item no. HY-128881-1ea
Manufacturer MedChem Express
CASRN 128300-15-2
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Molecules
Specific against other
Citations [1]Boger DL, et al. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity. Bioorg Med Chem. 1994 Feb;2(2):115-35.
Smiles O=C(N1C2=CC=C3NC(C(N4C5=CC=C6NC(C(N7C[C@](C8)([H])[C@]98C%10=CC=CC=C%10C(C=C79)=O)=O)=CC6=C5CC4)=O)=CC3=C2CC1)N
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
ADC Related
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
ADC Cytotoxin; DNA Alkylator/Crosslinker
Shipping Temperature
Room temperature
Molecular Weight
608.65
Product Description
(+)-CBI-CDPI2 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI2 is an antibody agent conjugates (ADCs) toxin.
Manufacturer - Research Area
Cancer
Solubility
10 mM in DMSO
Manufacturer - Pathway
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Isoform
Duocarmycins
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close